SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-17
👔
Tyra Biosciences, Inc.
@TYRA_InsiderForm 4 Filing: Rueb Yuliya Acquires (Grant) $27K of $TYRA
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Tyra Biosciences, Inc.
Ticker: $TYRA
Transaction Value
$27K
Price/Share: $9.13
transaction date
2026-09-15
Shares: 2,925
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Rueb Yuliya, holds the title of Vice President, Finance (PAO) at Tyra Biosciences, Inc..
On 2026-09-15, the insider transacted 2,925 shares.The shares were transacted at a weighted average price of $9.13 per share, resulting in a total market-relevant value of $27K.
Executive Summary Summary
Rueb Yuliya (Vice President, Finance (PAO)) was granted $27K of $TYRA
Post-Transaction Position: 11,258 shares
SEC Accession No: 0001193125-26-394734 (CIK: 2125370)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.